Loading…
Based on limited metadata, the FDA issued a warning letter to Nova Botanix LTD (doing business as CanaBD) on April 16, 2020, regarding drug products. Without access to the full warning letter text or subject line, the specific nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in the metadata provided.